Literature DB >> 28946972

Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) due to bortezomib in a case of light chain multiple mieloma. Treatment with tolvaptan.

Agustín Carreño1, Belén Hernández2, Ángel Mayoralas2, Carmen Calle2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28946972     DOI： 10.1016/j.nefro.2016.10.015

Source DB:  PubMed          Journal:  Nefrologia        ISSN： 0211-6995            Impact factor:   2.033


× No keyword cloud information.
  1 in total

1.  Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma.

Authors:  N O'Connor-Byrne; S Glavey; R Tudor; P Murphy; C J Thompson; J Quinn
Journal:  Exp Hematol Oncol       Date:  2019-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.